Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Eye Health Center

Font Size

Glaucoma, Alzheimer's Disease Linked

Scientists Spot the Same Protein in Both Diseases; Finding May Inspire New Glaucoma Treatments
WebMD Health News
Reviewed by Louise Chang, MD

Aug. 6, 2007 -- Scientists today announced that Alzheimer's disease and glaucoma share a risky protein called amyloid beta.

Targeting amyloid beta with Alzheimer's drugs may help treat glaucoma, according to the researchers, who work in the U.K. and elsewhere in Europe.

Amyloid beta is a key ingredient of the brain plaque seen in Alzheimer's patients. Amyloid beta is also associated with glaucoma, new research shows.

The findings come from M. Francesca Cordeiro, MRCP, PhD, and colleagues.

Cordeiro works at the Glaucoma and Retinal Degeneration Research Group at University College London's Institute of Ophthalmology. Her MRCP degree means she's a doctor who's a member of the U.K.'s Royal College of Physicians.

Glaucoma is a leading cause of blindness. Cordeiro's team studied glaucoma in rats, not people.

Due to glaucoma, the rats lost nerve cells in their eyes that transfer visual information from the eye to the brain, the researchers report. As that happened, amyloid beta built up in the area where those nerve cells had been.

To try to thwart that process, the scientists targeted amyloid beta with various types of drugs. That strategy reduced the number of nerve cells in the rats' eyes that died. The researchers got the best results when they gave the rats three types of drugs at once, instead of just one drug.

"We have shown that amyloid beta could be a particularly suitable target for therapeutic intervention in the eye" to help protect those nerve cells that glaucoma ravages, write Cordeiro and colleagues. Further research is needed to see if that approach will work in people.

In a news release, Cordeiro notes that "this doesn't mean that everyone with Alzheimer's will develop glaucoma or vice versa."

The findings appear in this week's early online edition of the journal Proceedings of the National Academy of Sciences.

Today on WebMD

Woman holding tissue to reddened eye
Learn about causes, symptoms, and treatments.
Simple annoyance or the sign of a problem?
red eyes
Symptoms, triggers, and treatments.
blue eye with contact lens
Tips for wearing and caring.
Understanding Stye
human eye
eye exam timing
vision test
is vision correction surgery for you
high tech contacts
eye drop